CAR-T（CAR-T）细胞疗法在非肿瘤性疾病中的应用
Chimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases.
CAR-T（CAR-T）细胞在血液系统恶性肿瘤中的应用推动了这种免疫治疗形式的显著进展。
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
在 CD19 CAR-T 细胞治疗中区分给药方案与疾病生物学。评论：“一种新的剂量密集策略用于 CD19 靶向 CAR-T 细胞治疗与 B 细胞非霍奇金淋巴瘤患者的持久缓解相关且不增加毒性”
英文原题：Separating dose schedule from disease biology in CD19 CAR T-cell therapy. Comment on: "A novel dose-dense strategy for CD19-directed CAR T-cell therapy is associated with durable responses without increased toxicity in patients with B-cell non-Hodgkin lymphoma".
查看英文原题
Separating dose schedule from disease biology in CD19 CAR T-cell therapy. Comment on: "A novel dose-dense strategy for CD19-directed CAR T-cell therapy is associated with durable responses without increased toxicity in patients with B-cell non-Hodgkin lymphoma".
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
中文摘要
暂无。
展开英文摘要原文
Not available.
论文信息
- 作者
- Jin Y、Fang Y、Yao Y
- 第一作者单位
- The First Affiliated Hospital of Dalian Medical University, Dalian, China; College of Laboratory Medicine, Dalian Medical University, Dalian.China
- 通讯作者单位
- The First Affiliated Hospital of Dalian Medical University, Dalian. Yix89@outlook.com.China
- 期刊
- Haematologica2026 Jul 23
- 原文标识
- PubMed 42489098 · DOI 10.3324/haematol.2026.301607